Bulk Inquiry
CEP-33779
- Soluble in 0.1N HCl(aq) and DMSO
- MF: C24H26N6O2S
- MW: 462.57
Description
CEP-33779 is a potent, selective and orally bioavailable JAK2 inhibitor with an IC50 value of 1.8 nM.
More Information
| Parent CAS No. | 1257704-57-6 |
|---|---|
| Chemical Name | N-(3-(4-Methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine |
| SMILES | N12N=C(NC3C=CC=C(N4CCN(C)CC4)C=3)N=C1C(C1C=CC(S(C)(=O)=O)=CC=1)=CC=C2 |
| MFCD | MFCD22683932 |
| InChi | InChI=1S/C24H26N6O2S/c1-28-13-15-29(16-14-28)20-6-3-5-19(17-20)25-24-26-23-22(7-4-12-30(23)27-24)18-8-10-21(11-9-18)33(2,31)32/h3-12,17H,13-16H2,1-2H3,(H,25,27) |
| InChiKey | RFZKSQIFOZZIAQ-UHFFFAOYSA-N |
| CID | 57336812 |
| Short Description | JAK2 inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1378 | AG 490 |
From $71.50 |
| 1588 | TG 101348 |
From $88.00 |
| 1598 | Ruxolitinib |
From $71.50 |
| 1681 | Momelotinib |
From $88.00 |
| 1778 | AZ 960 |
From $104.50 |
| 1843 | JAK2 inhibitor 13 |
From $121.00 |
| 1955 | Baricitinib |
From $77.00 |
| 2219 | AT 9283 |
From $99.00 |
| 2231 | XL 019 |
From $110.00 |
| 2316 | WP 1066 |
From $104.50 |
| 2554 | LY 2784544 |
From $104.50 |
| 2658 | MPT0B098 |
From $121.00 |
| 2792 | NVP-BSK805 |
From $137.50 |
| 3813 | BMS-911543 |
From Inquiry |
| 3855 | AZD-4205 |
From Inquiry |
| 3950 | Peficitinib |
From $132.00 |
| 3997 | ASN-002 |
From Inquiry |
| 4006 | GLPG-0634 |
From Inquiry |
| 4124 | Momelotinib hydrochloride |
From $132.00 |
| 4386 | JAK inhibitor I |
From $143.00 |
| 4393 | Ilunocitinib |
From $231.00 |
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.